One of the world’s largest loss of autonomy prevention programs is Occitane

[ad_1]

The goal of healthy aging

Proposed by the World Health Organization since 2019, the ICOPE program aims to promote “healthy” aging by improving the subjective capacity of the elderly subject, thanks to the regular monitoring of six essential functions for maintaining health. Independence: mobility, feeding, vision, hearing, mood and perception. The target of this preventive measure is the number of people aged 60 or over, independent and living at home, and its implementation depends mainly on the first-line actors: health professionals but also medical, social and social sector professionals.

ICOPE has been developed in Toulouse and Occitanie as part of INSPIRE, a public health project aimed at promoting healthy aging and therefore part of the addiction prevention that will concern 618 million people in the horizon 2050. INSPIRE is based on the partnership between the University of Toulouse III – Paul Sabatier, and the Hospital The University of Toulouse and Inserm, to which public and private partners are associated, including the Occitanie / Pyrénées-Méditerranée region, the local authorities of Haute-Garonne and the Occitanie Regional Health Agency with, in addition to support since 2019, a funded target of 50,000 senior beneficiaries of the software and tools enabling coordinated deployment in the region from 2022.

The ICOPE program is divided into 5 steps that can be implemented in the primary care sector:

  • Step 1: Examination,
  • Phase II: Integrated Assessment,
  • Step 3: Personal Care Plan,
  • Step 4: Follow up on the care plan,
  • Phase 5: Engaging communities and supporting caregivers.

Digital tools have been developed to facilitate screening testing (Step 1) and follow-up for subjects integrated into this care project. These are the ICOPE MONITOR mobile application, the ICOPEBOT chatbot and the ICOPE MONITOR database.

Since 2019, the Gérontopôle at the University Hospital of Toulouse, a WHO Collaborating Center, coordinated by Pr Bruno Vellas, has taken this opportunity and has been developing ICOPE for three years now in Occitanie, with the support and financial support of the Regional Health Agency of Occitanie, Region of Occitanie and POCTEFA (Program Interreg VA Spain-France-Andorra).

The INSPIRE ICOPE-CARE program confirms its importance

The study was conducted between January 2020 and November 2021 It is based on the inclusion of more than 10,000 people aged 60 or over, mainly in the Occitani region.

If other countries have also launched the prevention program deployment

ICOPE (China, India, Andorra, etc.), France The country that has so far combined the largest number of subjects into a digital collection” in the world, Allow today for an assessment.

The primary objective of this study was to describe the large-scale implementation of the ICOPE program and to inform the entire international community about the different stages of deployment of this public health programme.

A secondary objective was to allow a description of the prevalence of the different types of depression observed and the level of adherence of subjects to monitoring of their health status. It was also about making it possible to assess participant satisfaction, which is a key sign of program success.

Between January 1, 2020, and November 18, 2021, 10,903 older adults (mean age 76.0 years; 60.8% women) received their first screening test (ICOPE Phase 1), including 10,285 (94.3 %) with a positive scan. The most common impairments relate to vision, memory, hearing, mood, mobility, and weight loss.

Of these, 958 (9.3%) benefited from an in-depth assessment of their function (ICOPE Phase 2) and a personalized care plan (ICOPE Phase 3) which confirmed a decrease in subjective capacity in 865 (90.3%) participants.

Of the 7,367 participants eligible for follow-up (insert at least 6 months prior to November 18, 2021), 5,185 were in phase I for follow-up at 6 months, i.e. a follow-up commitment rate of 70.4%. A satisfaction survey conducted among 1,215 older adults participating in the INSPIRE ICOPE-CARE program (mean age 72.5 years, 55.6% women) found that 638 (52.5%) used digital tools with complete independence, 82 (6.7%) ) with the help of a relative and 495 (40.7%) assessed by a specialist.

Among those who used digital tools without assistance or with the help of a relative (n = 720), 563 (78.2%) were generally satisfied with the digital tool they used (ICOPE MONITOR or ICOPEBOT).

The large number of participants included, as well as their adherence over time, indicates that large-scale implementation of ICOPE in clinical practice is feasible. The high prevalence of positive screening tests, indicating a decrease in self-capacity, as well as higher rates of confirmed Phase 2 disability, shows that the INSPIRE ICOPE-CARE program targets people at increased risk of job loss. Effectively prevent addiction.

Today, Gérontopôle has included more than 20,000 seniors in the INSPIRE ICOPE-CARE programme. With the support of ARS Occitanie and the Ministry of Health and Prevention, 60,000 people aged 60 and over will be able to benefit from the program in Occitanie by 2025.

Under the momentum of the Ministry of Health, seven more French regions are also participating.

“WHO congratulates Toulouse University Hospital, its collaborating centre, for the deployment of the ICOPE approach, which includes the use of digital tools and the commitment of multidisciplinary teams in healthcare institutions”said Dr Anshu Banerjee, director of maternal, newborn, child, adolescent and aging health at the World Health Organization. “The study represents the first large-scale implementation of the ICOPE approach, thanks to the political commitment of the French government. The results of this publication will provide other countries with essential information to implement the programme.”

PDF
One of the world’s largest loss of autonomy prevention programs is Occitane
[922.4 ko]

[ad_2]

Source link


Posted

in

by

Tags:

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *